Research
December 19, 2022
U.S. Defense Department Awards UAMS Cancer Researcher $760,000 to Study Aggressive Type of Lymphoma
LITTLE ROCK — Samantha Kendrick, Ph.D., assistant professor in the Department of Biochemistry and Molecular Biology at the University of Arkansas for Medical Sciences (UAMS), has received a $760,000 grant from the U.S. Department of Defense to study a fast-growing type of non-Hodgkin lymphoma common among veterans and military personnel.
October 27, 2022
Four UAMS Researchers Receive Arkansas Breast Cancer Research 25th Anniversary Grants
The Arkansas Breast Cancer Research Program is celebrating its 25th year of funding breakthrough research by Arkansas scientists studying breast cancer. Since the program’s inception in 1997 with the passage of The Arkansas Breast Cancer Act, the annual grants program has awarded nearly $10 million in direct research support. UAMS administers the program. “Twenty-five years…
October 4, 2022
Marius Nagalo, Ph.D., Receives American Association for Cancer Research Award
University of Arkansas for Medical Sciences’ (UAMS) Bolni Marius Nagalo, Ph.D., is the recipient of the 2022 American Association for Cancer Research (AACR) Career Development Award. The $300,000 award will help Nagalo expand his novel research on virotherapy to treat advanced pancreatic ductal adenocarcinoma — work he is conducting in the labs at the UAMS…
June 10, 2022
Cancer Institute Retreat Highlights Novel Therapeutic Targets and Agents
The Winthrop P. Rockefeller Cancer Institute held its second annual scientific research retreat May 26 at the Marriott Hotel in Little Rock. More than 140 scientists gathered in person for the first time in two years. The retreat theme, “Molecular Targets and Cancer Therapeutics,” reflects the growth in the identification of new and novel molecular…
March 15, 2022
UAMS Study Finds Cancer Treatment Creates Employment Difficulties for Some Rural Women
LITTLE ROCK — Rural women are likely to face significant challenges finding secure and reliable employment following cancer treatment if they did not already have a secure job at the time of their diagnosis, according to a new study led by University of Arkansas for Medical Sciences (UAMS) researchers. The study, which was published in…
November 23, 2021
UAMS’ Analiz Rodriguez, M.D., Ph.D., Selected for Diversity in Clinical Trials Career Development Program
LITTLE ROCK — The Bristol Myers Squibb Foundation (BMSF), along with its partners National Medical Fellowships and the American Association for Cancer Research, selected University of Arkansas for Medical Sciences (UAMS) neurosurgeon Analiz Rodriguez, M.D., Ph.D., to participate in its Diversity in Clinical Trials Career Development Program.
November 15, 2021
UAMS Receives $18.9 Million NIH Award to Address Health Disparities
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has received $18.9 million from the National Institutes of Health (NIH) to support new research and interventions that will focus on reducing cancer and cardiovascular disease disparities among people who live in rural areas and African American populations across Arkansas. The five-year award from…
November 12, 2021
UAMS Biostatistics Contributes to Groundbreaking ANCHOR Study
The UAMS Department of Biostatistics played a key role in a successful national clinical trial to treat anal cancer in persons living with HIV. Jeannette Y. Lee, Ph.D., UAMS biostatistics professor and biostatistics leader for the Winthrop P. Rockefeller Cancer Institute at UAMS, served as the statistical center director for the National Cancer Institute’s (NCI)…
October 28, 2021
UAMS Researchers See 12% Increase in Grant Funding for FY2021
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) and its affiliate research institutions saw research funding grow by 12.2% this past year, with $177.4 million in grants by the end of the fiscal year on June 30. It is the second consecutive year with double-digit increases in research funding that comes from…
October 21, 2021
UAMS Participating in National Breast Cancer Screening Trial
The UAMS Winthrop P. Rockefeller Cancer Institute is participating in the National Cancer Institute’s TMIST (Tomosynthesis Mammographic Imaging Screening Trial). The study compares two standard breast cancer screening methods — tomosynthesis (3D) mammograms and digital (2D) mammograms — and is designed to help researchers determine whether one method is better than the other at finding…
Next page